89bio Clinical Study Site

Chattanooga, Tennessee 37421

1 studies enrolling now · 4 studies all time

What they study most

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis, NASH - Nonalcoholic Steatohepatitis, Severe Hypertriglyceridemia

Studies at this site

• A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) — Recruiting now
• To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia — Completed
• Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) — Completed
• Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia — Completed